Adamis Pharmaceuticals, based in San Diego, is working on an as-yet unnamed pre-filled syringe system for injecting epinephrine that would eliminate the problem of proper dosage in manual syringes, while saving patients money compared to EpiPens. A spokesperson for Adamis told MONEY that its product will cost at least 40% less than the current market price for an EpiPen pack. The product is currently under review by the FDA, and the company expects to starting selling them in 2017.